(Q64999056)

3 July 2019

title

Control of complement activation in membranous and membranoproliferative glomerulonephritis. (English)

1 reference

3 July 2019

author name string

Moseley HL

series ordinal

1

1 reference

3 July 2019

Whaley K

series ordinal

2

1 reference

3 July 2019

language of work or name

English

0 references

publication date

1 April 1980

1 reference

3 July 2019

published in

Kidney International

1 reference

3 July 2019

volume

17

1 reference

3 July 2019

issue

4

1 reference

3 July 2019

page(s)

535-544

1 reference

3 July 2019

https://scigraph.springernature.com/pub.10.1038/ki.1980.62

exact match

0 references

cites work

THE MACROMOLECULAR NATURE OF THE FIRST COMPONENT OF HUMAN COMPLEMENT

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

Modulation of the alternative complement pathways by beta 1 H globulin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

Control of the amplification convertase of complement by the plasma protein beta1H

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

Cobra Venom Factor: Evidence for Its Being Altered Cobra C3 (the Third Component of Complement)

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

Inactivator of the Third Component of Complement as an Inhibitor in the Properdin Pathway

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

Hyocomplementaemia and disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

Glomerular Complement Components in Human Glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

Glomerular deposition of properdin in acute and chronic glomerulonephritis with hypocomplementemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

Pathogenesis and approaches to therapy of membranoproliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

Dense deposit disease: a variant of membranoproliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

Classical complement pathway activation in membranoproliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

Properdin factor D. II. Activation to D by properdin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

Immunochemical quantitation of antigens by single radial immunodiffusion

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

Reaction mechanisms of beta1H globulin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

Interaction of beta1H globulin with cell-bound C3b: quantitative analysis of binding and influence of alternative pathway components on binding

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

Complement C3 convertase: Cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator

1 reference

https://api.crossref.org/works/10.1038%2FKI.1980.62

7 January 2021

Identifiers

DOI

10.1038/KI.1980.62

1 reference

3 July 2019

Dimensions Publication ID

0 references

1 reference

3 July 2019